title: Therapeutic perspectives.
abstract: Osteoporosis and atherosclerosis are linked by biological association. This encourages the search for therapeutic strategies having both cardiovascular and skeletal beneficial effects. Among drugs that may concordantly enhance bone density and reduce the progression of atherosclerosis we can include bisphosphonates (BP), statins, β -blockers, and possibly anti-RANKL antibodies. Available data come from experimental animals and human studies. All these treatments however lack controlled clinical studies designed to demonstrate dual-action effects.
authors.affiliation: Department of Internal Medicine, University of Catania, Catania, Italy.
authors.forename: Carmelo E
authors.initials: CE
authors.lastname: Fiore
authors.forename: Pietra
authors.initials: P
authors.lastname: Pennisi
authors.forename: Marianna
authors.initials: M
authors.lastname: Tinè